How cell type influences the impact of cancer-related protein activity in colorectal cancer
Research has revealed that the role of an important protein in colorectal cancer may vary significantly depending on which cells it is active in. The study, published in the journal npj Precision Oncology, shows that activity of a protein called mTOR may be associated with a stronger immune response in colorectal cancer when it is active in immune cells.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
